Amicus Therapeutics is a biotechnology company that develops and markets therapies for rare and orphan diseases, including treatments for Fabry and Pompe disease.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| PAULSON & CO. INC. (auto-surfaced) | 63 | New buy | 32,400 | $468,504 | 0.0% |
| George Soros / Soros Fund Mgmt | 31 | Added +15% | 5,753,186 | $83,191,070 | 0.9% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-07-20.